1. Home
  2. CIEN vs KVUE Comparison

CIEN vs KVUE Comparison

Compare CIEN & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ciena Corporation

CIEN

Ciena Corporation

HOLD

Current Price

$271.32

Market Cap

32.7B

Sector

Utilities

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$18.13

Market Cap

33.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIEN
KVUE
Founded
1992
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Specialty Chemicals
Sector
Utilities
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
32.7B
33.1B
IPO Year
1997
2023

Fundamental Metrics

Financial Performance
Metric
CIEN
KVUE
Price
$271.32
$18.13
Analyst Decision
Buy
Buy
Analyst Count
15
12
Target Price
$222.86
$19.58
AVG Volume (30 Days)
3.8M
56.6M
Earning Date
03-05-2026
02-17-2026
Dividend Yield
N/A
4.58%
EPS Growth
46.55
35.31
EPS
0.85
0.75
Revenue
$4,769,507,000.00
$15,006,000,000.00
Revenue This Year
$27.20
N/A
Revenue Next Year
$16.07
$2.72
P/E Ratio
$309.85
$24.25
Revenue Growth
18.79
N/A
52 Week Low
$49.21
$14.02
52 Week High
$285.97
$25.17

Technical Indicators

Market Signals
Indicator
CIEN
KVUE
Relative Strength Index (RSI) 58.05 65.38
Support Level $238.57 $17.14
Resistance Level $285.97 $18.22
Average True Range (ATR) 17.79 0.36
MACD 0.72 0.06
Stochastic Oscillator 62.37 85.53

Price Performance

Historical Comparison
CIEN
KVUE

About CIEN Ciena Corporation

Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Share on Social Networks: